Načítá se...
Engineering IgG-Like Bispecific Antibodies—An Overview
Monoclonal antibody therapeutics have proven to be successful treatment options for patients in various indications. Particularly in oncology, therapeutic concepts involving antibodies often rely on the so-called effector functions, such as antibody dependent cellular cytotoxicity (ADCC) and complem...
Uloženo v:
| Vydáno v: | Antibodies (Basel) |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6640676/ https://ncbi.nlm.nih.gov/pubmed/31544880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib7030028 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|